Blog

Osaka, Japan – A research team at Osaka University will start an investigator-initiated clinical trial for refractory prostate cancer patients after successful development of a new alpha-ray therapeutic agent ([At-211] PSMA-5) and confirmation of its efficacy in animal models. This will be a world-first in-human

New research from Memorial Sloan Kettering Cancer Center (MSK) investigates a promising approach against diabetic retinopathy and finds patients with early-onset colorectal cancer likely don’t need more frequent surveillance colonoscopies. Credit: Memorial Sloan Kettering Cancer Center New research from Memorial Sloan Kettering Cancer Center (MSK)

“We have identified binding motifs within the C-tails of PAR1,2&4, indispensable for cancer growth and development.” Credit: 2024 Nag et al. “We have identified binding motifs within the C-tails of PAR1,2&4, indispensable for cancer growth and development.” BUFFALO, NY- May 24, 2024 – A new

The Experimental Drug Development Centre (EDDC), Singapore’s national platform for drug discovery and development, is pleased to announce that the Phase 1 trial for EBC-129 has progressed into dose expansion.  Credit: EDDC The Experimental Drug Development Centre (EDDC), Singapore’s national platform for drug discovery and

Sepsis, a life-threatening complication of infections, poses a severe threat to cancer patients, whose compromised immune systems make them highly susceptible. In a study published in Science Bulletin, researchers led by Hong-Da Chen from the Peking Union Medical College Hospital, Chinese Academy of Medical Sciences

Recently, a research group led by Dr. JIANG Yanyi from Hefei Institutes of Physical Science of Chinese Academy of Sciences, along with Dr. LIN Dechen’s team at the University of Southern California, USA, revealed the tumor-extrinsic function of master regulator transcription factor-TP63 in promoting immune

Vaccinia viruses are therapeutic tools with different biomedical applications depending on the susceptibility characteristics. For example, the strain called MVA (modified vaccinia Ankara), which is unable to replicate in mammalian cells, triggers a potent immune system response and is used to develop vaccines against COVID-19

Enhancing drug development for life-threatening diseases like cancer hinges on a deep understanding of protein kinases, making it a focal point for researchers. These enzymes, encoded by more than 500 human genes, serve as critical players in cellular signaling pathways. However, if these signals are

MIAMI, FLORIDA (MAY 23, 2024) – The treatment landscape for multiple myeloma, the second most common blood cancer, is shifting rapidly, with newly diagnosed patients increasingly being treated with a four-part drug combination that includes a new immunotherapy agent. Credit: Photo by Sylvester MIAMI, FLORIDA

MIAMI, FLORIDA (May 23, 2024) – Coral Olazagasti expected a relatively smooth transition when she moved to New York to start her residency after graduating from medical school in her native Puerto Rico. But that proved wishful thinking. Credit: Photo by Sylvester MIAMI, FLORIDA (May